Core Insights - Collegium Pharmaceutical, Inc. announced four poster presentations featuring real-world data on its ADHD product, Jornay PM, at the APSARD Annual Conference from January 15-18, 2026 [1][2] Group 1: Product Information - Jornay PM is a central nervous system stimulant indicated for the treatment of ADHD in individuals aged 6 years and older, utilizing a novel delayed-release extended-release delivery platform [1][11] - The poster presentations will cover various aspects of Jornay PM, including optimal dosing, risk-benefit evaluation compared to Concerta, changes in functioning, and effects on depression and anxiety severity in adults [3] Group 2: Company Strategy - Collegium is focused on enhancing clinical decision-making through sustained investment in real-world evidence generation, aiming to improve care for ADHD patients [2] - The company is building a diversified biopharmaceutical portfolio, with ADHD as a key growth driver, and is committed to disciplined capital deployment [12]

Core Insights - Ten large-cap stocks experienced significant declines last week, indicating potential concerns in their respective sectors and overall market sentiment [2]. Group 1: Stock Performance - Astera Labs, Inc. (NASDAQ:ALAB) lost 23.85% this week [2] - Nebius Group N.V. (NASDAQ:NBIS) lost 16.10% this week [2] - Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS) lost 14.56% this week, influenced by comments from Treasury Secretary Bessent regarding potential buyback reductions [2] - IonQ, Inc. (NYSE:IONQ) fell 17.69% this week amid ongoing weakness in the quantum computing sector [2] - AeroVironment, Inc. (NASDAQ:AVAV) slumped 9.87% this week, also affected by Bessent's remarks [2] - F5, Inc. (NASDAQ:FFIV) fell 11.69% this week after a security breach linked to China-backed hackers [2] - Klarna Group (NYSE:KLAR) fell 8.64% last week [2] - Leonardo DRS, Inc. (NASDAQ:DRS) fell 9.15% last week [2] - Tempus AI, Inc. (NASDAQ:TEM) slumped 5.89% last week, despite entering a collaboration with Whitehawk Therapeutics, Inc. [2] - First Horizon Corporation (NYSE:FHN) lost 10.42% this week following the release of quarterly results [2]